Volume 3 Issue 6 will be published on November 08, 2022   A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation ¡ª published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences¡ªis a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: The rising in the popularity of big data, artificial intelligence, and simulation technologies has opened up new opportunities for the development of our society. The close integration of real and artificial societies has become a trend, bringing in novel concepts such as parallel society and metaverse. The artificial society system describes, predicts, and guides the real society system, in a closed-loop, iterative, and spiral-rising way, forming a new mode of social operation driven by Data-AI-Simulation techniques. In the future, with the further development of interdisciplinary cooperation and the continuous advancement of technologies, living in metaverse is within reach.
Position: Home > Collections > Cancer
> Editorial
Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges
--Lin Shen
> Article
Paclitaxel and Cisplatin with or without Cetuximab in metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label Phase II trial
--Zhihao Lu et al.
> Perspective
Searching for unity in diversity of animal magnetoreception: From biology to quantum mechanics and back
--Can Xie
> Report
DCLK1 autoinhibition and activation in tumorigenesis
--Linna Cheng et al.
> Article
Profiling of immune features to predict immunotherapy efficacy
--Youqiong Ye et al.
> News & Buzz
China enters CAR-T cell therapy era
--Xin Cao et al.
> Review
Nanotechnology-enhanced immunotherapy for metastatic cancer
--Peisen Zhang et al.
> Article
ClusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data
--Tianzhi Wu et al.
> Review
Acquired Resistance to Third-generation EGFR-TKIs and Emerging Next-generation EGFR Inhibitors
--Xiaojing Du et al.
> Report
Small Molecular NIR-II Fluorophores for Cancer Phototheranostics
--Hanming Dai et al.
> Review
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
--Chang Gu et al.
> Translational Patent
Innovative Irinotecan-Loaded Nanomicelles Will Enter Phase I Clinical Trial in 2021
--Chan Li et al.
> Review
Overcoming resistance to drugs targeting KRASG12C mutation
--Delong Jiao et al.
> Review
Insights into hepatitis B virus DNA Integration-55 years after virus discovery
--Kaitao Zhao et al.
> Review
Therapy of primary liver cancer
--Mei Feng et al.
> Report
Assessment of spine tumor treatment using implanted 3-dimensional-printed vertebral bodies with robotic stereotactic radiotherapy.
--Hongqing Zhuang et al.
> Review
Current status and future perspective of immunotherapy in gastrointestinal cancers
--Zhihao Lu et al.

 

Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry
COVID-19
Environment Changes
Geoscience
Life Science
Materials
Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  the.innovation.journal
  The Innovation
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org
  Official£º
Astronomy£º
Chemistry£º
Geoscience£º
Informatics£º
Life Science£º
Management£º
Materials£º
Medicine£º
Physics£º
ScienceX£º

@The_InnovationJ
@Innov_Astronomy
@InnovationChem
@Innov_Geosci
@Innov_inf
@Innov_LifeSci
@Innov_MGT
@Innov_Materials
@Innov_Medicine
@InnovationPhys
@Innov_ScienceX

  Copyright © 2019-2022 the-innovation.org All Rights Reserved